AQR Arbitrage’s ZyVersa Therapeutics, Inc. Warrants ZVSAW Stock Holding History

AQR Arbitrage’s Portfolio ZVSAW Stock Details ZVSAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-138,981	Closed	-$17K	–	1366
2022 Q3	$17K	Hold	138,981	–	–	﹤0.01%	1040
2022 Q2	$15K	Hold	138,981	–	–	﹤0.01%	1163
2022 Q1	$24K	Buy	+138,981	New	+$28.1K	﹤0.01%	1084

AQR Arbitrage's ZVSAW Position: Q4 2022 in Review

AQR Arbitrage sold out of ZyVersa Therapeutics, Inc. Warrants (ZVSAW) in Q4 2022, closing a stake of 138,981 shares — an estimated $17K sold.

AQR Arbitrage first reported a position in ZVSAW in Q1 2022 and held it in 3 quarters. The position peaked at $24K in Q1 2022. 1 fund tracked by Wall St. Rank holds ZVSAW as of Q4 2022.

AQR Arbitrage reported no remaining ZyVersa Therapeutics, Inc. Warrants position as of Q4 2022 after selling out during the quarter.
AQR Arbitrage sold 138,981 ZyVersa Therapeutics, Inc. Warrants shares in Q4 2022, an estimated $17K.
AQR Arbitrage first reported a position in ZyVersa Therapeutics, Inc. Warrants in Q1 2022 and held it in 3 quarters.
AQR Arbitrage's ZyVersa Therapeutics, Inc. Warrants position peaked at $24K in Q1 2022.
1 fund tracked by Wall St. Rank held ZyVersa Therapeutics, Inc. Warrants as of Q4 2022.

Based on AQR Arbitrage's 13F filing for Q4 2022, filed 14 Feb 2023.